250 related articles for article (PubMed ID: 22960888)
1. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study.
Prasad K; Mohanty S; Bhatia R; Srivastava MV; Garg A; Srivastava A; Goyal V; Tripathi M; Kumar A; Bal C; Vij A; Mishra NK
Indian J Med Res; 2012 Aug; 136(2):221-8. PubMed ID: 22960888
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.
Taguchi A; Sakai C; Soma T; Kasahara Y; Stern DM; Kajimoto K; Ihara M; Daimon T; Yamahara K; Doi K; Kohara N; Nishimura H; Matsuyama T; Naritomi H; Sakai N; Nagatsuka K
Stem Cells Dev; 2015 Oct; 24(19):2207-18. PubMed ID: 26176265
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.
Kumar A; Prasad M; Jali VP; Pandit AK; Misra S; Kumar P; Chakravarty K; Kathuria P; Gulati A
Acta Neurol Scand; 2017 May; 135(5):496-506. PubMed ID: 27558274
[TBL] [Abstract][Full Text] [Related]
6. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
7. Intravenous autologous bone marrow mononuclear cells for ischemic stroke.
Savitz SI; Misra V; Kasam M; Juneja H; Cox CS; Alderman S; Aisiku I; Kar S; Gee A; Grotta JC
Ann Neurol; 2011 Jul; 70(1):59-69. PubMed ID: 21786299
[TBL] [Abstract][Full Text] [Related]
8. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.
Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N
Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
[TBL] [Abstract][Full Text] [Related]
10. Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients.
Hammadi AMA; Alhimyari F
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):239-241. PubMed ID: 30777565
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone-marrow mononuclear stem cell therapy in patients with stroke: a meta-analysis of comparative studies.
Chumnanvej S; Chumnanvej S
Biomed Eng Online; 2020 Sep; 19(1):74. PubMed ID: 32993677
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.
Honmou O; Houkin K; Matsunaga T; Niitsu Y; Ishiai S; Onodera R; Waxman SG; Kocsis JD
Brain; 2011 Jun; 134(Pt 6):1790-807. PubMed ID: 21493695
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
Moniche F; Cabezas-Rodriguez JA; Valverde R; Escudero-Martinez I; Lebrato-Hernandez L; Pardo-Galiana B; Ainz L; Medina-Rodriguez M; de la Torre J; Escamilla-Gomez V; Ortega-Quintanilla J; Zapata-Arriaza E; de Albóniga-Chindurza A; Mancha F; Gamero MA; Perez S; Espinosa-Rosso R; Forero-Diaz L; Moya M; Piñero P; Calderón-Cabrera C; Nogueras S; Jimenez R; Martin V; Delgado F; Ochoa-Sepúlveda JJ; Quijano B; Mata R; Santos-González M; Carmona-Sanchez G; Herrera C; Gonzalez A; Montaner J
Lancet Neurol; 2023 Feb; 22(2):137-146. PubMed ID: 36681446
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.
Cox CS; Hetz RA; Liao GP; Aertker BM; Ewing-Cobbs L; Juranek J; Savitz SI; Jackson ML; Romanowska-Pawliczek AM; Triolo F; Dash PK; Pedroza C; Lee DA; Worth L; Aisiku IP; Choi HA; Holcomb JB; Kitagawa RS
Stem Cells; 2017 Apr; 35(4):1065-1079. PubMed ID: 27800660
[TBL] [Abstract][Full Text] [Related]
17. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.
Battistella V; de Freitas GR; da Fonseca LM; Mercante D; Gutfilen B; Goldenberg RC; Dias JV; Kasai-Brunswick TH; Wajnberg E; Rosado-de-Castro PH; Alves-Leon SV; Mendez-Otero R; Andre C
Regen Med; 2011 Jan; 6(1):45-52. PubMed ID: 21175286
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
19. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
[TBL] [Abstract][Full Text] [Related]
20. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke.
Friedrich MA; Martins MP; Araújo MD; Klamt C; Vedolin L; Garicochea B; Raupp EF; Sartori El Ammar J; Machado DC; Costa JC; Nogueira RG; Rosado-de-Castro PH; Mendez-Otero R; Freitas GR
Cell Transplant; 2012; 21 Suppl 1():S13-21. PubMed ID: 22507676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
